12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Monday's intraday session, several healthcare stocks experienced significant price movements. Gainers included INVO Bioscience, Timber Pharmaceuticals, Pasithea Therapeutics, Regencell Bioscience, Replimune Group, and Scilex Holding. Losers were Bellerophon Therapeutics, Castle Biosciences, Mallinckrodt, PDS Biotechnology, HTG Molecular Diagnostics, and Elevation Oncology.
June 05, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
INVO Bioscience stock rose 50.9% to $0.32 during Monday's session, with a trading volume of 5.4 million and a market cap of $4.4 million.
INVO Bioscience's stock price rose significantly during Monday's session, indicating a positive short-term impact. The high trading volume and market cap also contribute to the stock's potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Pasithea Therapeutics shares moved upwards by 24.99% to $0.5, with a trading volume of 1.0 million and a market cap of $13.0 million.
Pasithea Therapeutics' stock price increased significantly during Monday's session, indicating a positive short-term impact. The high trading volume and market cap also contribute to the stock's potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Replimune Group stock rose 20.85% to $22.95, with a trading volume of 656.2K and a market cap of $1.3 billion.
Replimune Group's stock price increased significantly during Monday's session, indicating a positive short-term impact. The high trading volume and market cap also contribute to the stock's potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Regencell Bioscience shares increased by 22.22% to $27.5, with a market value of $357.8 million.
Regencell Bioscience's stock price increased significantly during Monday's session, indicating a positive short-term impact. The market value also contributes to the stock's potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Scilex Holding stock moved upwards by 20.74% to $7.74, with a trading volume of 321.0K and a market value of $1.1 billion.
Scilex Holding's stock price increased significantly during Monday's session, indicating a positive short-term impact. The high trading volume and market value also contribute to the stock's potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Timber Pharmaceuticals stock increased by 38.92% to $2.07, with a trading volume of 12.3 million and a market value of $6.3 million.
Timber Pharmaceuticals' stock price increased significantly during Monday's session, indicating a positive short-term impact. The high trading volume and market value also contribute to the stock's potential for growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bellerophon Therapeutics stock declined by 85.4% to $1.03, with a trading volume of 9.4 million and a market value of $10.7 million.
Bellerophon Therapeutics' stock price declined significantly during Monday's session, indicating a negative short-term impact. The high trading volume and market value, however, suggest that there may be potential for recovery.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Castle Biosciences stock fell 47.61% to $11.91, with a trading volume of 6.3 million and a market cap of $317.8 million.
Castle Biosciences' stock price declined significantly during Monday's session, indicating a negative short-term impact. The high trading volume and market cap, however, suggest that there may be potential for recovery.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Elevation Oncology shares declined by 20.77% to $2.81, with a trading volume of 2.8 million and a market value of $68.2 million.
Elevation Oncology's stock price declined significantly during Monday's session, indicating a negative short-term impact. The high trading volume and market value, however, suggest that there may be potential for recovery.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
HTG Molecular Diagnostics stock declined by 20.86% to $1.68, with a trading volume of 247.1K and a market cap of $3.7 million.
HTG Molecular Diagnostics' stock price declined significantly during Monday's session, indicating a negative short-term impact. The high trading volume and market cap, however, suggest that there may be potential for recovery.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt stock fell 41.23% to $1.44, with a trading volume of 643.9K and a market value of $18.9 million.
Mallinckrodt's stock price declined significantly during Monday's session, indicating a negative short-term impact. The high trading volume and market value, however, suggest that there may be potential for recovery.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
PDS Biotechnology stock decreased by 26.53% to $6.92, with a trading volume of 6.7 million and a market cap of $213.3 million.
PDS Biotechnology's stock price declined significantly during Monday's session, indicating a negative short-term impact. The high trading volume and market cap, however, suggest that there may be potential for recovery.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100